Exclusives

Surgenex has initiated a 180-patient RCT comparing Pellograft for treatment of DFUs and SanoGraft for treatment of VLUs vs SoC with primary outcome of 100% epithelialization of DFUs at 12 weeks and VLUs at 16 weeks. Recruitment has begun with...

Facial device-related pressure injuries (DRPIs) from N95 masks were observed. A quality improvement project showed that silicone adhesive tape reduced DRPIs, w/ 82.7% of participants reporting greater comfort and improved well-being.WPR...

The EWMA document “Negative Pressure Wound Therapy: Overview, Challenges and Perspectives” from 2017 has been updated now. The paper describes the available technologies and applications and provides hands-on clinical guidance on NPWT.

Aroa reported they are expanding the MASTRR study to 15 sites and 800 patients (previous target of 10 sites and 300 patients) and will leverage data from the 300 enrollments completed to date to publish study results based on sub-group...

The first clinical trials of Urgo’s artificial skin project should begin in two years w/ marketing expected in 2032. This will first occur in the US, where the product category already exists, making its authorization and management simpler...

In a 20-patient bilateral breast reduction surgery study, the Prevena Restor BellaForm NPWT dressing on one breast vs the SOC dressing on the other showed reduced drain output on the Prevena side but no difference in LOS or scar appearance at...

StimLabs announced enrollment of the first patient in the CAMPSTIM multi-center RCT that aims to demonstrate the clinical outcomes of at least four of StimLabs' placental-based tissue products with standard of care (SOC) vs SOC alone in...

Kerecis announced it has received approval from Palmetto GBA for the Kerecis Shield used in private doctor clinics. The approval means that 4 of the 7 insurance companies administering Medicare plans across the US have set a fee schedule for...

IR-MED received a $500,000 grant from the Israel Innovation Authority to develop its platform technology for early detection of DFUs. DiaSafe is being developed to provide safe, real-time optical readings of biomarkers to detect the early...